Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Randomized phase II trial to compare the effectiveness of two regimens of rebeccamycin
analogue in treating women who have stage IIIB or stage IV breast cancer. Drugs used in
chemotherapy use different ways to stop tumor cells from dividing so they stop growing or
die. The best way to give rebeccamycin analog in breast cancer patients is not yet known